affinity purification coupled to mass spectrometry (ap-Ms) is the method of choice for analyzing protein-protein interactions, but common protocols frequently recover only the most stable interactions and tend to result in low bait yield for membrane proteins. Here, we present a novel, deep interactome sequencing approach called copIt (co-interacting protein identification technology), which allows comprehensive identification and analysis of membrane protein interactomes and their dynamics. copIt integrates experimental and computational methods for a coimmunoprecipitation (co-Ip)-based workflow from sample preparation for mass spectrometric analysis to visualization of protein-protein interaction networks. the approach particularly improves the results for membrane protein interactomes, which have proven to be difficult to identify and analyze. copIt was used successfully to identify the interactome of the cystic fibrosis transmembrane conductance regulator (cFtr), demonstrating its validity and performance. the experimental step in this case achieved up to 100-fold-higher bait yield than previous methods by optimizing lysis, elution, sample clean-up and detection of interacting proteins by multidimensional protein identification technology (MudpIt). Here, we further provide evidence that copIt is applicable to other types of proteins as well, and that it can be successfully used as a general co-Ip method. the protocol describes all steps, ranging from considerations for experimental design, co-Ip, preparation of the sample for mass spectrometric analysis, and data analysis steps, to the final visualization of interaction networks. although the experimental part can be performed in <3 d, data analysis may take up to a few weeks.
IntroDuctIon
The proper functioning of an organism is orchestrated by highly complex protein networks, which are dynamically regulated in time and space. AP-MS has become an important method of advancing the discovery and functional characterization of such networks by facilitating the analysis of protein-protein interactions 1, 2 . Discovering protein interaction networks is still challenging, however, because a comprehensive analysis requires high yields of the 'bait' protein for robust co-purification of its interactors, to enable differentiation of true interactors from nonspecific background and to allow comparisons between different samples based on relative quantification of proteinprotein interactions.
The generally lower abundance, hydrophobic nature and partial protection of protease cleavage sites by lipid layers exacerbate experimental and analytical challenges for membrane proteins. Because of these technical challenges, the interactome of many membrane proteins has remained unknown or is only poorly characterized. Yet, because membrane proteins make up about a third of the human genome; include many physiologically important proteins such as ion channels, transporters and receptors; and represent the majority of the 'druggable genome' [3] [4] [5] [6] , there is a particular need for elucidating the interactomes of membrane proteins. Shotgun proteomic methods have improved the identification of membrane proteins and topology mapping, but these methods are not compatible with the identification of protein interaction partners [7] [8] [9] [10] [11] [12] [13] . The study of membrane protein interactomes is therefore often performed with baits that are tagged with an epitope. Although epitope-tagging strategies can provide efficient enrichment because of the availability of high-affinity reagents and antibodies, epitope tagging increases the potential for mis-sorting or misfolding of membrane proteins during their complex biogenesis [14] [15] [16] and may render AP-MS data potentially less informative 17, 18 . Once mass spectrometric data are acquired and proteins in the sample are identified, the data need to be analyzed to rank interactors according to confidence, construct interactomes and finally visualize interactome networks and changes thereof. Several recently published methods, including SAINT 19, 20 , CompPASS 21 and MiST 22 , address these issues for AP-MS experiments performed with epitope-tagged proteins but either do not provide an integrated solution from experiment to network for immunoprecipitations of nontagged proteins or require prior knowledge such as typical background in the immunoprecipitations or expected interactors.
To facilitate the identification and analysis of membrane protein interactomes, we developed a novel, highly sensitive 'deep proteomic interactome profiling approach', called CoPIT 23, 24 .
CoPIT is an experimental and computational framework that allows the comprehensive characterization of endogenous membrane interactomes, as well as nonmembrane protein interactomes, in three individual workflows, as illustrated in Figure 1 . First, an optimized experimental protocol for Co-IP provides enhanced sensitivity and efficiency by addressing several issues associated with enrichment of protein interactomes in general and with membrane protein interactomes in particular, which are (i) highly efficient recovery of membrane proteins from cell lysates while preserving interactions; (ii) insolubility and aggregation of membrane proteins during IP and subsequent elution; (iii) removal of lipids and other contaminants that may cause signal suppression during electrospray ionization; and (iv) compatibility of the Co-IP procedure and sample cleanup with in-solution digestion, chromatographic separation and mass spectrometric detection. The second workflow includes novel data analysis algorithms, which allow an unbiased discrimination of highly confident from less confident interactors in comparison with control
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experiments for label-free data, as well as allowing the researcher to determine interactome changes between experimental conditions using spectral counting. Finally, interacting proteins can be graphed in a specialized network visualization tool (Radial Topology Viewer) that maps interactors, for example, according to statistical significance of the interactions, whereby the arithmetic distance to the bait in the center reflects the statistical significance. The arithmetic distance to the bait can also reflect a dynamic variable of the user's choice-for example, confidence of interaction or change in strength of interaction (e.g., fold change). Additional relational information on protein-protein interactions gathered from other databases can be included as well to enable the contextual interpretation of a protein interactome.
The CoPIT method was developed to determine the interactome of the CFTR, an ion channel with 12 transmembrane segments that belongs to the ABC transporter family [25] [26] [27] , and to compare it against the interactome of the most common CFTR mutation, an in-frame deletion of phenylalanine 508, which causes cystic fibrosis in 70-90% of all cystic fibrosis patients 28 . CFTR can be considered a touchstone for methods that aim at determining membrane protein interactomes, because of its low abundance (≤100 molecules per cell for the HBE41o − cell line), aboveaverage protein size (168 kDa), rapid turnover in the cell and short protein half-life 29, 30 -all of which contribute to difficulties associated with membrane protein analysis. In summary, CoPIT enables the comprehensive characterization of a membrane protein interactome. This is true not only for highly abundant membrane proteins but also for low-abundance membrane proteins such as CFTR, as long as an antibody with good immunoprecipitation capabilities is available-even if only low starting amounts of sample are provided. These characteristics make CoPIT ideal for comparative interactome analysis of neuronal receptors and membrane proteins in different brain regions or cell types (e.g., the synaptic interactome) for example. In addition, the capability and applicability of CoPIT to other types of proteins are illustrated with IPs for the peripheral membrane protein glucocerebrosidase (GC), the soluble protein kinase SMG1, as well as the transcription factor Tet2 (Fig. 2) . It is important to bear in mind that the success of any immunoprecipitation is dependent on a high-quality antibodyantigen interaction, and quantitative immunoprecipitation of the antigen (the bait protein) has to be established before attempting CoPIT experiments.
Experimental design
The success and sensitivity of CoPIT depend on the inclusion of proper controls. CoPIT does not rely on pre-established lists of background or contaminant proteins, because the determination of what is background in an actual experiment greatly varies with the choice of the bait, and cellular or organismal model system. Instead, CoPIT relies on an unbiased statistical approach that makes use of the high recovery of bait and interactors, and a set of specific control experiments (c), which determine the level of background within the CoPIT procedure (overview in Fig. 3) . Appropriate controls are 'mock' IPs that are performed with beads devoid of any antibody in order to determine the background caused by nonspecific binding to the beads. Because antibodies might bind antigens other than the antigen of interest in a cell, samples that are devoid of the bait protein should be used in an additional set of control experiments. Ideally, an isogenic cell line or tissue that does not express the bait protein is available for this purpose or can be generated with current gene editing tools. If the protein is essential to cell viability, RNA interference might be an option to at least transiently downregulate the antigen of interest by >10-fold. We do not recommend using Co-IPs with antibodies against proteins 'unrelated' to the intended bait as controls, because in this case the interactomes of two different proteins are compared, rather than a bait-unspecific background being subtracted. Results of such experiments are difficult to interpret and may result in an unwanted bias in the interactome, as proteins that truly interact with the bait and the 'unrelated' protein are removed during subsequent data analysis. Because of the high sensitivity of the mass spectrometry instrumentation, efficient removal of other contaminants before mass spectrometry is further required for highest sensitivity and reproducibility of the analysis. Contaminating lipids are a particular problem for membrane protein analysis because they impede both the tryptic digest of proteins and the mass spectrometric detection of peptides by contributing to signal suppression and by increasing the complexity of mass spectra. Therefore, CoPIT takes several precautions to reduce background at different steps during the procedure. First, samples are precleared using nonantibody-coupled beads to reduce the background of proteins that bind nonspecifically to the beads. Second, antibody-coupled beads are saturated with antibody during the coupling procedure to maximize antigen retrieval and to minimize nonspecific binding of contaminant proteins and, third, excess lipids, as well as the detergent and salts, are removed by precipitation with a mixture of methanol and chloroform before proteolytic digest of the sample (Fig. 3a) .
Although mass spectrometry of proteins is a very sensitive detection method, it is heavily dependent on the quality of the immunoprecipitation itself and cannot correct for suboptimal performance of the Co-IP. Thus, it is recommended that the suitability of an antibody for Co-IP be tested first in a small-scale experiment followed by western blotting. Not all antibodies are suitable for Co-IP, and success of the method is greatly dependent on the affinity and specificity of the antibody, which need to be determined empirically for each new bait. Finding the best antibody for an immunoprecipitation of interest can be a substantial effort. Sometimes, it can be quicker and more successful to test a different antibody than trying to further modify experimental conditions in hopes of improving the performance of a relatively poor immunoprecipitation. In general, we greatly prefer to use monoclonal antibodies for CoPIT because large amounts of antibody can be generated in hybridoma cell lines at reasonable cost to ensure saturation of the beads with the antibody. Saturation of the beads to maximum capacity helps prevent nonspecific binding of proteins and concentrates protein complexes of interest in a small volume. In general, the binding capacity of the Sepharose beads ranges from 5 to 15 mg/ml (milligrams of antibody per milliliter of packed beads). Antibodies should be coupled to the beads at this ratio, and coupling and cross-linking efficiency should be checked by SDS electrophoresis, as pointed out in the protocol. Another critical variable is the starting amount of the sample. The main parameters that influence how much starting material is required and thereby determine the success of a CoPIT experiment are as follows: the abundance of the bait protein per cell, the relative contribution of the cell type of interest in a tissue preparation and the affinity of the antibody for the bait. Therefore, it is good practice to carefully consider cell and tissue preparation and enrichment techniques before sample lysis for immunoprecipitation. We suggest starting with 1 × 10 8 cells for low-abundance bait proteins such as CFTR. Samples can be prepared with much success from much lower numbers of cells, depending on the above parameters and to a small degree on the experience of the person performing the experiment. • •
MaterIals

REAGENTS
Buffer A Buffer A is 95% H 2 O, 5.0% MeCN and 0.1% formic acid.
EQUIPMENT SETUP Fritted microcapillary column (MudPIT microcapillary column)
This column should be prepared as described elsewhere [31] [32] [33] .  crItIcal To avoid cross-contamination between the different samples, each sample should be loaded onto a separate, freshly prepared column. The number of MudPIT columns needed is identical to the number of replicates, as well as to the number of experimental conditions and controls.
MudPIT: This should be set up as described elsewhere 13, 34 . Mass spectrometer setup The procedure has been successfully carried out using LTQ, LTQ Orbitrap, LTQ Velos and Velos Pro Orbitrap, as well as Orbitrap Elite mass spectrometers (all from Thermo Fisher). The MudPIT approach 13, 33 to run samples is recommended for the greatest yield of bait and interactors. Briefly, purified peptides are resuspended in 50 µl of buffer A and pressure-loaded onto the back end of a preparative MudPIT microcapillary column consisting of fused silica (i.d. 250 µm) packed in-house with 2.5 cm of 5-µm Aqua C 18 resin and 2.5 cm of strong cation exchange resin. The preparative column should be connected by a small union body to an analytical reversed-phase column (115-mm fused silica, i.d. 100 µm) packed with 3-µm Aqua C 18 resin.
In our laboratory, samples were analyzed by nano-electrospray ionization-C/LC-S/MS on an LTQ-Orbitrap XL, LTQ or Orbitrap Elite mass spectrometer by placing the triphasic MudPIT column inline with an Agilent quaternary HPLC pump and separating the peptides in multiple dimensions with a modified six-step gradient containing 0, 20, 40, 60 and 100% of buffer C (500 mM ammonium acetate, 5% MeCN, 0.1% formic acid) over 12 h or a 10-step gradient (0-90% buffer C) over 20 h, as described previously 13 . Each full-scan mass spectrum (400-2,000 m/z) was followed by 6 (LTQ or LTQ-Orbitrap XL) or 20 (Orbitrap Elite, Velos or Velos Pro) data-dependent MS/MS scans at 35% normalized collisional energy and an ion count threshold of 1,000 (LTQ-Orbitrap XL, Elite or Velos) or 500 counts (LTQ). Dynamic exclusion was used with an exclusion list of 500, repeat time of 60 s and asymmetric exclusion window of −0.51 and +1. proceDure coupling of antibodies to sepharose beads • tIMInG ~4.5 h  crItIcal 100 mM Sodium Borate, pH 9.0, and 200 mM Ethanolamine, pH 8.0, solutions should be freshly prepared. pH must be adjusted exactly; otherwise, the cross-linking reaction may be inefficient. Avoid any contamination of these buffers with primary amines from sources such as pH meter devices.  crItIcal To check for cross-linking efficiency, after Steps 2, 3, 6 and 8, take small sample aliquots of antibody or beads, and run an SDS-PAGE gel (10%) and stain with Coomassie Brilliant Blue G-250. 1| Add the appropriate amount of Sepharose beads to a microcentrifuge tube and wash four times with 10 volumes of Dulbecco's PBS (DPBS). Spin the suspension at 500g for 3 min at room temperature (RT; 25 °C).
2| Remove excess DPBS. Add the appropriate amount of antibody to the beads. Save a small aliquot corresponding to 1 µg of antibody for an SDS-PAGE gel control ('input'). Gently mix the antibody and beads for 2 h at RT on a rotator to allow binding of the antibody to the beads.  crItIcal step Never let the Sepharose beads become dry.
3|
Centrifuge the binding suspension for 3 min at 500g at RT. Wash the beads twice with 10 bead volumes of 100 mM sodium borate, pH 9.0. Save a small aliquot corresponding to 1 µg of antibody bound to beads for an SDS-PAGE gel control ('bound'). 13| Scrape off the cell lysate with a large cell scraper and transfer it to a 1.5-ml microcentrifuge tube.
14|
Sonicate the cell lysate for 3 min in a water-bath sonicator operating at 55 kHz.  crItIcal step Do not use a probe sonicator, as this will result in loss of interactors.
15| Centrifuge the mixture for 30 min (18,000g, 4 °C).
16| Preclear the cell lysate with an appropriate amount of Protein G Sepharose 4 Fast Flow beads (100 µl of 50% slurry in lysis buffer) for 2 h at 4 °C with head-over-head rotation. The volume of preclear beads should be the same as the volume of antibody-coupled beads. For volumes larger than 1.4 ml, pool the cell lysates and transfer them to a 15-ml tube.
17|
Centrifuge the mixture for 3 min at 500g at 4 °C.
18|
Transfer the supernatant to a new microcentrifuge tube containing the appropriate amount of antibody-coupled Sepharose slurry (e.g., 100 µl of 50% antibody slurry, equaling 200 µg of antibody for a starting amount of ≈10 mg). Incubate the suspension overnight with head-over-head rotation at 4 °C. 21| Centrifuge the suspension for 3 min at 500g at 4 °C, carefully remove supernatant and wash the beads two times with TN wash buffer.
22|
Carefully remove all of the supernatant with an insulin syringe.  pause poInt The beads can be stored at −80 °C for up to 2 weeks. 23| (Optional) Freeze the beads for >1 h at −80 °C to increase the yield in the following steps.
24|
Elute the proteins twice with at least four to ten bead volumes of elution buffer for 20 min at 37 °C, with shaking.
25|
Combine the eluates and transfer them to a new microcentrifuge tube.  crItIcal step Make sure to get no beads into the eluate, as they might clog the microcapillary columns and produce background signal later in the mass spectrometer. 
29|
Centrifuge the mixture for 10 min at 18,000g at 4 °C.
30|
Remove the supernatant without disturbing the pellet. Note: The pellet may be very tiny or hardly visible at all.
31| Wash the pellet with 3 volumes (vol/vol) of methanol.
32| Centrifuge the mixture for 10 min at 18,000g at RT.
33|
Remove the supernatant without disturbing the pellet.  pause poInt The pellet can be stored at −80 °C for up to 4 weeks.
Digestion of eluted proteins • tIMInG ~15 h 34|
Resolubilize the methanol/chloroform-precipitated proteins (pellet) in 100 mM Tris, pH 8.5, and 0.2% Rapigest and sonicate for 1 h in a water-bath sonicator (Branson).
35|
Reduce cysteine disulfide bonds with TCEP (5 mM final concentration) for 20 min.
36|
Alkylate reduced cysteine residues with 10 mM iodoacetamide (final concentration) or chloroacetamide for 30 min. The reaction should be shielded from light.
37|
Digest proteins with recombinant trypsin (30:1 ratio of protein to trypsin) overnight at 37 °C with shaking (e.g., in an Eppendorf Thermomixer).
38|
Inactivate Rapigest by adding formic acid to 9% final concentration and incubate for at least 1 h at 37 °C, with shaking.
39|
Reduce the samples to near dryness in vacuo using a vacuum concentrator (~45 min).  pause poInt Samples can be stored at −80 °C for up to 4 weeks.
40|
Resolubilize the sample in a small amount of buffer A, load it onto a preparative MudPIT column and perform a MudPIT run, as described in refs. 32,33. 42| Search the MS/MS spectra for matching peptide sequences using an appropriate protein database that is well annotated. It is advised to include a reversed or scrambled database of the same size to allow for an estimation of the false-discovery rate.
Data analysis • tIMInG ~2 d to several weeks
43|
Combine search engine results from MS/MS spectra for all biological replicates before assigning peptides to proteins and filtering the results-for example, by using DTASelect 2.1. We strongly recommend conservatively filtering and adjusting the false-positive rates to a peptide false-positive rate of <0.5%, and a protein false-positive rate of <1.0%. Experiments with insufficient recovery of bait (for example, bait protein not within the top ten most identified proteins or <50 SpC as a guideline) may be discarded.  crItIcal step Ambiguities in protein identification caused by peptides matching to multiple protein isoforms should be resolved because the resulting redundancy is problematic for statistical analysis, as it skews the analysis toward proteins with many isoform entries. The current CoPIT approach is based on a 'gene-centric' strategy. Therefore, all protein isoforms are assigned to their respective genes by converting the protein ID to Entrez Gene symbols. This is important when isoform-exhaustive databases are used. For the global analysis of the interactome, CoPIT currently retains the highest intensity value obtained from the different isoforms identified.
Determination of the protein interactors that are specific  crItIcal To distinguish specific protein interactors from nonspecifically binding proteins, perform the following steps in MATLAB (Mathworks) or similar software. Alternatively, run CoPIT.jar, which performs Steps 44-49 and is available at http://proteomicswiki.com/wiki/index.php/CoPITgenerator. All steps for using the software are documented on that website. , where n is the number of independent measurements of experimental condition e or of control condition c. The number of biological replicates n should be similar for the two conditions.  crItIcal step The identification of proteins enriched in bait-specific immunoprecipitations is based on two approximations: first, proteins binding nonspecifically and nonselectively to beads or antibody are detected in both experimental and control measurements. As shown before 35, 36 , the frequency distribution for nonenriched proteins can be assumed to follow a normal distribution, which is centered close to r pec =1.0, as all nonspecific proteins are expected to be detected with equal intensities in both control and experimental conditions. Second, bait-interacting proteins can be grouped as high-and lowabundance interactors. Interactors of high abundance have high intensity values and show large excess over control values (r pec >>1), clearly indicating enrichment. Less-abundant interactors may represent a weak or transient interaction or an interaction with the bait that happens only in a very specific subcellular location. Such interactors are typically measured at lower levels (r pec >1). To delineate a specificity of interaction, CoPIT assumes that the distribution of specific interactors follows a normal distribution independent of the normal distribution of proteins binding nonspecifically to beads or antibodies only. The center of this second normal distribution depends significantly on the yield of the immunoprecipitations, as higher yields result in larger signal intensities and thus in a larger contribution of the specific binding intensity to the ratio r pec .
45|
Determine the frequency distribution of all r pec ratios: bin the frequency distribution with 25-30 bins (in intervals of 0.1-0.2), depending on the sample measured, and generate a histogram covering a range of binned ratios ρ (ρ min to ρ max , typically −2 to +4). network representation and data presentation 50| Obtain interactions between the identified interactors with the GeneMANIA 2.2 Plugin in Cytoscape 2.8. 2 (refs. 37,38) and export connectivity information to a .txt or .csv file to load into Radial Topology Viewer.
Step-by-step instructions on how to obtain networks from GeneMania and Cytoscape are available in Morris et al. 39 . Detailed instructions on how to load and visualize data in Radial Topology Viewer are provided at http://proteomicswiki.com/wiki/index.php/ RadialTopologyViewer. Radial Topology Viewer particularly enables a user to define the length of each individual edge in a network (e.g., according to strength of interaction), and it allows users to group proteins, e.g., based on annotation information or other relational information. This information should be provided in a .txt or .csv file.
? trouBlesHootInG Troubleshooting advice can be found in table 1. Too few antibody-coupled beads were used or too many beads were lost during the procedure
Use an insulin syringe to remove solutions during washing of the co-immunoprecipitate. Check that sufficient quantities of antibody have been coupled to the beads and enough beads were used for the Co-IP procedure
The pH of the solutions was incorrect
All solutions need to have the correct pH, in particular the lysis buffer and the elution buffer. It is critical that detergent be added to the elution buffer for elution of membrane proteins (Fig. 2e) . It should be noted that the yield of an IP varies depending on the suitability of the antibody. For instance, recovery of CFTR could be further increased by using a different anti-CFTR antibody (monoclonal antibody 24-1, R&D Systems), which resulted in up to 3,441 spectral counts (316 peptides) from a single IP and MudPIT run, with 5 mg of protein from a whole-cell lysate as a starting amount and use of an LTQ Orbitrap Elite. A successful experiment should be further reflected in high sequence coverage of the bait and its interactors: for example, up to 60% of CFTR could be covered in a single experiment, and up to 71% could be covered with additional nontryptic digest. High sequence coverage in a single run could also be achieved for the other baits, with 68.8% for GC, 56.3% for SMG1, which is an exceptionally large kinase of 410 kDa, and 81.6% for Tet2 (supplementary Fig. 1a) . In addition, a successful experiment will also increase recovery and sequence coverage for interacting proteins (supplementary Fig. 1b) . If neither high spectral counts for the bait nor high sequence coverage are observed, each step of the experimental protocol should be carefully assessed for mistakes, and the suitability of the antibody for the IP should be confirmed. Usually the bait is within the ten proteins recovered with the highest spectral counts in an experiment. The success of the second step of CoPIT critically builds on the quality of the results obtained in the first step. To achieve sufficient discriminative power to differentiate specific from nonspecific interactors, a broad coverage of the interactome, as well as of background proteins, is required, and thus it heavily depends on a robust performance of the liquid chromatography (LC), as well as best detection sensitivity of the mass spectrometric setup. Usually, best results are achieved using a MudPIT experimental setup rather than a single reverse-phase setup, because MuPIT greatly reduces ion suppression due to coeluting ions. In addition, using MudPIT instead of a single reverse-phase approach will increase the recovery of peptides, in particular of hydrophobic ones (supplementary Fig. 2) .
In the frequency distribution of the relative amount of interactors to background shown for CFTR CoPIT experiments (Fig. 3c) , the left ascending flank reflects the ascending slope of the distribution of nonspecific binding proteins, assuming a normal distribution that is centered close to 0. The left-most descending flank of the observed distribution of proteins represents weak specific interactors that are also present in the background interactome and that are assumed to follow a second normal distribution. Strong interactors show up at the outmost right tail of the descending flank of this second normal distribution. In addition to a good P value (typically P ≥ 0.9), the interacting protein should be detected in at least two independent biological replicates of the same experimental condition to be considered an interactor.
We tested this approach by comparing the scores obtained for typical, putative background proteins, such as keratins and antibody sequences, and for established CFTR interactors, such as HSP90 and HSP70, which are also often detected in the general background and thus challenge any method used to discriminate the interactor from background. Results show that background protein candidates were eliminated based on low confidence scores, whereas known CFTR interactors, including Hsp70 and Hsp90, were identified with high specificity (Fig. 3d) . This procedure allows the determination of high-confidence interactors for each experimental condition; these constitute a respective core interactome. In addition, an extended interactome can be defined, which additionally contains all medium-confidence interactors that are enriched but fail to pass the stringent criteria set for high-confidence interactors.
The third step in CoPIT is tailored to comparing and visualizing the results obtained. The comparison of individual experimental conditions is based on counting statistics and associated errors, because the way a mass spectrometer acquires spectra in data-dependent mode can be described as a counting experiment, thus also relying on a large number of interactors identified. This contrasts with data analysis frameworks for Co-IPs tailored to experiments that identify only a small number of highly specific interactors across a range of baits.
A further challenge in proteomic analysis of immunoprecipitations can be the variability in absolute spectral counts between individual experiments. This variability has been attributed in part to the limitations of data-dependent acquisition by the mass spectrometer and in part to variation between biological experiments. In CoPIT, individual immunoprecipitation experiments are therefore normalized to differences in the amount of whole-cell lysate (e.g., starting material) and differences in the abundance of the bait protein to compensate for changes in expression of the bait protein upon, for example, a specific treatment. In addition, P value cutoffs for interactors should and can be adjusted according to the ratio of bait protein between two experimental conditions. For example, interactors of ∆F508 CFTR required twofold-higher r pec values than WT CFTR (P ≥0.93), because about twice as much CFTR was recovered from ∆F508 CFTR immunoprecipitations than from WT CFTR immunoprecipitations. Although flexible tools for network representation are readily available (such as Cytoscape and Osprey), CoPIT uses a specialized network viewer named Radial Topology Viewer, which is based on Medusa 40 . The quantitative relationship of the interacting protein with the bait is reflected in the length of individual edges creating an 'interactome-radar', which can help to quickly distinguish strong and weak interactions based on their distance to the bait, whereas grouping by ontological information allows easy identification of cellular processes in which a particular interactor or group of interactors is involved (Fig. 4) .
Interpretation of results
Although the complexity of a specific protein interactome certainly depends on the protein of interest, a large but specific interactome may be rationalized by an estimation of the degrees of interaction. On the basis of the CFTR interactome, an estimated 20-25 first-degree interactors directly bind to CFTR at different stages of its life cycle. These interacting proteins reflect essentially different subcellular compartments to which ∆F508 CFTR localization can be tethered according to specific steps or specific time points during its biogenesis, and can be visualized by grouping interactors according to subcellular function using the Radial Topology Viewer. Accordingly, the connectivity between nodes is highest within the individual functional groups for the CFTR interactome map. Thus, in each specific subcellular compartment or time PSMA8   TM9SF3   TMEM165   PSMB4  PSMB5   PSMB2   SNX27   EPCAM   PSMB3   LMAN2  PSMB1   RPL14   CLPTM1   RPL15   YTHDF3   AGK   PKM2   LRPPRC   TM9SF2   PSMC6   ABCB10   PSMC3   FABP5   PSMC4   PSMC2  RAB3B   PARK7   AUP1   FBXO21   RPL10A   IPO7   IPO4   NPEPPS   TUBB6   CDH3   IPO9   LAMP1   CDH1   TUBB3   RUVBL2   TUBB1   RUVBL1   KPNA6   KPNA2   ANKRD13A   TPM4   TPM2   TPM1   TRAFD1   ACLY   EBNA1BP2   FSCN1   FKBP8   ERH   KIAA0406   DSC1   PECI   KPNB1   SNRPA   RAB5B   RAB5C   GLO1   UBR4   ARL1   THADA   PHB   SPATA5   HSP90B1   SLC9A3R2   VTN   BAG2   BAG3   UBR5   TPR   PGK1   SEC16A   GFPT1   EEF2   IARS   RAB5A   TUBA8   ITGB1   SLC25A3   MCM7   ITGB4   PPP6R3   TNPO3   DSP   RFC5   UNC45A   ACTR3   EIF5A   PPP1R12A   CHUK   ITGA3   RFC2   ITGA2 point ∆F508 CFTR appears to interact with a few primary interactors, followed by secondary interacting proteins. Given that the average shortest distance from one protein to the next protein is 4.1 in the human proteome and the average number of interacting proteins ranges from 1.8 to 3.9 (depending on the study), 80-100 proteins are expected as second-degree interactors of the initial 20-25 first-degree interactors of CFTR. With CoPIT, we provide evidence for third-degree interactors, which we expect to number 320-400 proteins. Thus, the total number of proteins that directly and indirectly interact with CFTR can be estimated to be roughly 420-525 proteins, which is in the range of the interactome size that was determined experimentally with CoPIT. This estimation also explains the larger size of the ∆F508 CFTR interactome relative to the WT CFTR interactome. Difficulties in translation, insertion into the endoplasmic reticulum, folding, enhanced degradation and altered trafficking of ∆F508 CFTR all contribute to an increased and more diverse interactome for ∆F508 CFTR.
